Cefaclor (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cefaclor" in English language version.

refsWebsite

Global rank English rank

4^th place

2^nd place

11^th place

8^th place

447^th place

338^th place

3^rd place

low place

1^st place

low place

399^th place

333^rd place

books.google.com

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 493. ISBN 9783527607495.

Hebert AA, Sigman ES, Levy ML (November 1991). "Serum sickness-like reactions from cefaclor in children". Journal of the American Academy of Dermatology. 25 (5 Pt 1): 805–808. doi:10.1016/S0190-9622(08)80973-5. PMID 1802903.
Parra FM, Igea JM, Martín JA, Alonso MD, Lezaun A, Sainz T (August 1992). "Serum sickness-like syndrome associated with cefaclor therapy". Allergy. 47 (4 Pt 2): 439–440. doi:10.1111/j.1398-9995.1992.tb02086.x. PMID 1456417. S2CID 46029579.
King BA, Geelhoed GC (December 2003). "Adverse skin and joint reactions associated with oral antibiotics in children: the role of cefaclor in serum sickness-like reactions". Journal of Paediatrics and Child Health. 39 (9): 677–681. doi:10.1046/j.1440-1754.2003.00267.x. PMID 14629499. S2CID 25762196.
Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G (May 1993). "Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication". American Journal of Obstetrics and Gynecology. 168 (5): 1393–1399. doi:10.1016/s0002-9378(11)90771-6. PMID 8498418.

Hebert AA, Sigman ES, Levy ML (November 1991). "Serum sickness-like reactions from cefaclor in children". Journal of the American Academy of Dermatology. 25 (5 Pt 1): 805–808. doi:10.1016/S0190-9622(08)80973-5. PMID 1802903.
Parra FM, Igea JM, Martín JA, Alonso MD, Lezaun A, Sainz T (August 1992). "Serum sickness-like syndrome associated with cefaclor therapy". Allergy. 47 (4 Pt 2): 439–440. doi:10.1111/j.1398-9995.1992.tb02086.x. PMID 1456417. S2CID 46029579.
King BA, Geelhoed GC (December 2003). "Adverse skin and joint reactions associated with oral antibiotics in children: the role of cefaclor in serum sickness-like reactions". Journal of Paediatrics and Child Health. 39 (9): 677–681. doi:10.1046/j.1440-1754.2003.00267.x. PMID 14629499. S2CID 25762196.
Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G (May 1993). "Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication". American Journal of Obstetrics and Gynecology. 168 (5): 1393–1399. doi:10.1016/s0002-9378(11)90771-6. PMID 8498418.
Satterwhite JH, Cerimele BJ, Coleman DL, Hatcher BL, Kisicki J, DeSante KA (1992). "Pharmacokinetics of cefaclor AF: effects of age, antacids and H2-receptor antagonists". Postgraduate Medical Journal. 68 (Suppl 3): S3–S9. PMID 1287615.

"Summary of Cefaclor's use during lactation". LactMED. U.S. National Library of Medicine. Retrieved 22 May 2011.

Parra FM, Igea JM, Martín JA, Alonso MD, Lezaun A, Sainz T (August 1992). "Serum sickness-like syndrome associated with cefaclor therapy". Allergy. 47 (4 Pt 2): 439–440. doi:10.1111/j.1398-9995.1992.tb02086.x. PMID 1456417. S2CID 46029579.
King BA, Geelhoed GC (December 2003). "Adverse skin and joint reactions associated with oral antibiotics in children: the role of cefaclor in serum sickness-like reactions". Journal of Paediatrics and Child Health. 39 (9): 677–681. doi:10.1046/j.1440-1754.2003.00267.x. PMID 14629499. S2CID 25762196.

"Cefaclor Susceptibilty and Resistance Data" (PDF). TOKU-E. 18 August 2014. Archived from the original (PDF) on 2016-03-03. Retrieved 2013-08-13.

"Cefaclor Susceptibilty and Resistance Data" (PDF). TOKU-E. 18 August 2014. Archived from the original (PDF) on 2016-03-03. Retrieved 2013-08-13.